Miragen Therapeutics – Consensus Indicates Potential 36.8% Upside

Broker Ratings

Miragen Therapeutics found using ticker (MGEN) have now 4 analysts covering the stock. The analyst consensus points to a rating of ‘Buy’. The target price ranges between 44 and 18 and has a mean target at 31.5. With the stocks previous close at 23.03 this is indicating there is a potential upside of 36.8%. The day 50 moving average is 19.64 and the 200 day moving average is 16. The market capitalisation for the company is $90m. Visit the company website at: 0


You can now share this on Stocktwits, just click the logo below and add the ticker in the text to be seen.

Share on Stocktwits

Good news travels fast (but only if you make that happen):

Share on twitter
Share on linkedin
Share on facebook
Share on email
Share on reddit

AIM All Share Index